BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ECT TREATMENT

    MDR report key: 11693616 · Received April 20, 2021

    Report

    Report Number
    MW5100862
    Event Type
    Injury
    Date Received
    April 20, 2021
    Report Date
    April 19, 2021
    Manufacturer
    UNK
    Product Code
    GXC
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    IL, US
    Reporter Occupation
    PATIENT

    Narratives

    Description of Event or Problem · 1

    I WAS ASSURED IT WILL HELP. I WASN'T TOLD ABOUT PAST BRAIN DAMAGE EFFECTS. I HAVE BECAME EVEN MORE SUICIDAL AFTER TREATMENT. RAGE, CONSTANT FOG AND CAN'T FOCUS OR CONCENTRATE. EXTREMELY SHORT TERM MEMORY AFFECTING WORK AND PERSONAL LIFE. DEVELOPED LABORED BREATHING RIGHT AFTER LAST TREATMENT. ORIGINAL I THOUGHT IT WAS SINUS OR ALLERGIES, IT'S NOT. I WAS EXCITED TO FEEL BETTER AFTER TREATMENT. DOCTOR WAS HORRIBLE AND BEFORE THEY KNOCKED ME OUT, I NOTICED WE LEFT THE ROOM. I WAS ENTRUSTING HIM NOT THESE OTHER PEOPLE WITH ZAPPING MY BRAIN. DUE TO THE EFFECTS, NOT COVID QUARANTINE. I'VE LOST ALL OF MY ABILITIES I WAS ABLE TO DO BEFORE, LOST FRIENDS, I CAN BARELY WORK OUT, BARELY WORK AND SUICIDAL DAILY MORE THAN I'VE EVER FELT IN MY LIFE. PLUS I CAN'T BREATH. I STOPPED LEAVING THE HOUSE. THIS HAS RUINED MY LIFE. I HAD 3 ECT TREATMENTS. FDA SAFETY REPORT #: (B)(4).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    594035 ECT TREATMENT DEVICE, ELECTROCONVULSIVE THERAPY GXC UNK

    Patients

    Seq Age Sex Outcome Treatment
    1 Other| S ADDERALL | WELLBUTRIN (WHICH NO LONGER WORKING) | XANAX